These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 5334614)

  • 41. [1-dopa for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1102-3. PubMed ID: 5450048
    [No Abstract]   [Full Text] [Related]  

  • 42. A double-blind controlled study of MK-486 in Parkinson's disease.
    Schwartz AM; Olanow CW; Spencer A
    Trans Am Neurol Assoc; 1973; 98():301-3. PubMed ID: 4594189
    [No Abstract]   [Full Text] [Related]  

  • 43. Parkinsonism.
    Stern G
    Br Med J; 1969 Nov; 4(5682):541-2. PubMed ID: 5354854
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
    Sirtori CR; Bolme P; Azarnoff DL
    N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733
    [No Abstract]   [Full Text] [Related]  

  • 45. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U
    Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract]   [Full Text] [Related]  

  • 46. Levodopa therapy effects on natural history of Parkinsonism.
    Stern PH; McDowell F; Miller JM; Robinson MB
    Arch Neurol; 1972 Dec; 27(6):481-5. PubMed ID: 4628440
    [No Abstract]   [Full Text] [Related]  

  • 47. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
    Court J; Kase JC; Mena I; Palacios E
    Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
    [No Abstract]   [Full Text] [Related]  

  • 48. L-dopa for parkinsonism.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
    [No Abstract]   [Full Text] [Related]  

  • 49. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Biol Psychiatry; 1970 Oct; 2(4):341-66. PubMed ID: 4920729
    [No Abstract]   [Full Text] [Related]  

  • 50. [Levodopa treatment in parkinsonism].
    Rinne UK; Sonninen V; Siirtola T
    Duodecim; 1971; 87(12):933-47. PubMed ID: 5088232
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of parkinsonism with L-dopa].
    Court J; Kase JC; Palacios E; Mena I
    Rev Med Chil; 1971 Jun; 99(6):399-401. PubMed ID: 5561157
    [No Abstract]   [Full Text] [Related]  

  • 52. Serial determinations of homovanillinic acid in the cerebrospinal fluid of Parkinson patients treated with L-dopa.
    Bertler A; Jeppsson PG; Nordgren L; Rosengren E
    Acta Neurol Scand; 1971; 47(4):393-402. PubMed ID: 4941731
    [No Abstract]   [Full Text] [Related]  

  • 53. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA; Campanella G
    Acta Neurol (Napoli); 1971; 26(1):46-60. PubMed ID: 5553941
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D
    Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
    [No Abstract]   [Full Text] [Related]  

  • 55. Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
    Knopp W
    Neurology; 1970 Dec; 20(12):Suppl:23-30. PubMed ID: 4921585
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C
    Br Med J; 1970 Feb; 1(5692):331-7. PubMed ID: 4906702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levodopa and orphenadrine hydrochloride in Parkinsonism.
    Whyte RK; Hunter KR; Laurence DR; Stern GM; Armitage P
    Eur J Clin Pharmacol; 1971 Dec; 4(1):18-21. PubMed ID: 4948768
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined treatment of parkinsonism with L-dopa and amantadine.
    Hunter KR; Stern GM; Laurence DR; Armitage P
    Lancet; 1970 Sep; 2(7672):566. PubMed ID: 4195220
    [No Abstract]   [Full Text] [Related]  

  • 59. Sustained-release levodopa in parkinsonism.
    Eckstein B; Shaw K; Stern G
    Lancet; 1973 Feb; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract]   [Full Text] [Related]  

  • 60. Gout while receiving levodopa for Parkinsonism.
    Honda H; Gindin RA
    JAMA; 1972 Jan; 219(1):55-7. PubMed ID: 5066588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.